(Q53954672)

English

The PROTECT Study: final results of a large multicenter postmarketing study in patients with type 2 diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies.

scientific article published in March 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

The PROTECT Study: final results of a large multicenter postmarketing study in patients with type 2 diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies. (English)

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Buse J

1

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

Hart K

2

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

Minasi L

3

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

publication date

1 March 1998

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

Clinical Therapeutics

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

20

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

2

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

257-269

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

PROTECT interim results: a large multicenter study of patients with type II diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(98)80089-1

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9589817

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53954672&oldid=1400445394"